01
Dr. Reddy’s Partners with ISB to promote Research in Employability and Skilling
- Establishes Dr. Reddy’s Cell for Employability and Skilling’ at the ISB
View Details
01
Dr. Reddy’s launches darbepoetin alfa in India under the brand name ‘Cresp®’
World’s first generic darbepoetin alfa and the only one in India
View Press Release
Cresp in brief
02
Dr. Reddy’s Annual Report 2009-10 released
SUSTAINABILITY: Creating a positive economic social & environmental impact
Download PDF
View e-Version
03
Dr. Reddy’s Named Best Workplace In Biotech/ Pharma Industry
Dr. Reddy’s has, for the second consecutive year, been ranked the Best Workplace in the biotech/ pharmaceutical industry in India in a survey conducted by The Economic Times and the Great Place to Work Institute.
View Details
04
Dr. Reddy’s receives AmeriCares Special Award for Haiti Earthquake relief
Dr. Reddy’s bags the “Americares Spirit of Humanity Awards” – Special Award for Haiti Earthquake Relief on March 08, 2010.
View Details
05
Exploit your strengths before exploring further
Dr. Reddy's is today a more nimble and agile organisation.
thanks to the various lessons learnt along the way.
View Details
06
Dr. Reddy's bags the NASSCOM-CNBC IT User Award again!
View Details
07
Dr. Reddy's lauded for Corporate Social Responsibility at the CNBC - IBLA 2009
View Details
08
Dr. Reddy's bags award at the SAFA Best Presented Accounts Awards 2008
View Details
09
ACS Green Chemistry Institute®
Dr. Reddy's joins American Chemical Society Green Chemistry Institute® Pharmaceutical Roundtable as an associate member.
View Press release
10
Dr. Reddy's launches Strea™ Professional in India
View Pressrelease
10
Promius Pharma Launches Promiseb™ Cream
View Pressrelease
10
Dr. Reddy's launches Finrid™ in India
View Pressrelease
10
Dr. Reddy's Annual General Meeting
July 22, 2009, Hyderabad
View Details
0877
Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F
View Press Release
View 20-F Filing
09
Dr. Reddy’s Annual Report 2008-09 released
View Report
10
Dr. Reddy’s launches Bispec™ in India
View Press Release
10
Dr. Reddy’s announces strategic alliance with GSK for Emerging Markets
View Press Release
09
Dr. Reddy’s announces ANDA approval of Omeprazole Mg OTC
View Press Release
10
Dr. Reddy's conducts Analysts and
Investors Meet
21st May, 2009
Mumbai
Click here to View Presentation
10
Dr. K Anji Reddy receives AIF (American India Foundation) Award 2009
Read More
10
Dr. Reddy’s inaugurates its Leadership Academy.
The Leadership Academy is a one stop resource center for leadership development, training and development needs for the global workforce of Dr. Reddy’s.
100
Dr. Reddy’s announces Q4 FY09 results.
Dr. Reddy’s FY09 Revenues at Rs. 69,441 million, EBITDA at Rs. 14,505 million
View Press Release
1010
Dr. Reddy’s Laboratories announce settlement of Clarinex® (Desloratadine) ANDA patent litigation with Schering Corporation and Sepracor Inc
101
Dr. Reddy’s (betapharm) receives preliminary results on AOK tender in Germany.
betapharm has been tentatively offered 8 products in different regions of Germany covering the AOK-insured persons.
10
Dr. Reddy’s honoured at the HDMA Annual Leadership Forum.
Dr. Reddy’s North America Generic Team was recently honoured at the HDMA Annual Leadership Forum held in Washington DC.
109
RedituxTM named ‘Product of the Year 2008’ by the Indian biotechnology magazine BioSpectrum.
Reditux was declared “Product of the Year” by the Indian biotechnology magazine, Biospectrum on Dec 12, 2008. It is a tribute to the efforts of the Biologics team of Dr. Reddy's
111
Dr. Reddy’s launches authorized generic version of Imitrex®* Tablets.
Dr. Reddy’s became the first company to launch an authorized generic version of GlaxoSmithKline’s Imitrex® (sumatriptan succinate) tablets (25mg, 50mg, and 100mg ) in the US market
10
Dr. Reddy’s wins the ‘Company with Best CSR & Sustainability Practices 2008’ award.
Dr. Reddy’s was conferred the ‘Company with Best CSR & Sustainability Practices 2008’ by The Asian Centre for Corporate Governance & Sustainability and the Indian Merchants Chamber.
